EUVIMEDEUVIMED entdecken
Crossref

SARS-CoV-2 main protease inhibition by natural compounds

Gisele Strieder Philippsen, Lucas Yudai Nozaki, Michael Jackson Vieira da Silva, Juliana Nakamura, Erika Seki Kioshima, Fernanda Andreia Rosa, Flavio Augusto Vicente Seixas

Bioorganic & Medicinal Chemistry Letters · 2026-08 · 137 · 130664

DOI: 10.1016/j.bmcl.2026.130664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026-08. Verfasst von Gisele Strieder Philippsen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Paraná, Brazil. Electronic address: gistrieder@ufpr.br. Hauptthemen laut MEDLINE: SARS-CoV-2, Protease Inhibitors, Antiviral Agents, Biological Products. Die Arbeit nennt 69 Literaturangaben. Gefördert von: CAPES, CNPq, Araucaria Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pandemic caused by the SARS-CoV-2 virus established the urgency in the development of vaccines and specific antivirals. Currently, vaccines and one specific medicine (Paxlovid) are available. Despite this, the research for therapeutic resources is still active to expand the possibilities for COVID-19 treatment. In this work, the libraries of natural compounds from Sigma-Aldrich and Molport were computationally screened, aiming to identify potential inhibitors against the SARS-CoV-2 main protease. The compounds SID336241534, SID264573190, and SID336181660 were identified as potential ligands and had their inhibitory activity against SARS-CoV-2 main protease confirmed by the in vitro proteolytic activity assays, suggesting their use as leads for the optimization of more efficient inhibitors. The in vivo and clinical tests are still needed to explore the applicability of the prospected compounds for the COVID-19 treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Protease InhibitorsAntiviral AgentsBiological ProductsCoronavirus 3C ProteasesBetacoronavirusHumansMolecular Docking SimulationMolecular Dynamics SimulationStructure-Activity Relationship

Stichwörter der Autor:innen

Molecular docking simulationMolecular dynamics simulationProteolytic activity assaySARS-CoV-2 main protease

Substanzen

Protease InhibitorsAntiviral AgentsBiological ProductsCoronavirus 3C Proteases

Autor:innen und Institutionen

  • Universidade Federal do Paraná, Brazil. Electronic address: gistrieder@ufpr.br.
  • Department of Technology, Universidade Estadual de Maringá, Umuarama, PR, Brazil.
  • Universidade Tecnológica Federal do Paraná, Toledo, PR, Brazil. Electronic address: michaeljsilva@utfpr.edu.br.
  • Graduate Program in Biosciences and Pathophysiology, Universidade Estadual de Maringá, Maringá, PR, Brazil.
  • Department of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá, PR, Brazil. Electronic address: eskcotica@uem.br.
  • Department of Chemistry, Universidade Estadual de Maringá, Maringá, PR, Brazil. Electronic address: farosa@uem.br.

Förderung

  • CAPES
  • CNPq
  • Araucaria Foundation

Zitieren

APA

Philippsen, G. S., Nozaki, L. Y., da Silva, M. J. V., Nakamura, J., Kioshima, E. S., Rosa, F. A., & Seixas, F. A. V. (2026). SARS-CoV-2 main protease inhibition by natural compounds. Bioorganic & Medicinal Chemistry Letters, 137, 130664. https://doi.org/10.1016/j.bmcl.2026.130664

Vancouver

Philippsen GS, Nozaki LY, da Silva MJV, Nakamura J, Kioshima ES, Rosa FA, et al. SARS-CoV-2 main protease inhibition by natural compounds. Bioorganic & Medicinal Chemistry Letters. 2026;137:130664. doi:10.1016/j.bmcl.2026.130664

BibTeX
@article{Philippsen2026,
  author = {Philippsen, Gisele Strieder and Nozaki, Lucas Yudai and da Silva, Michael Jackson Vieira and Nakamura, Juliana and Kioshima, Erika Seki and Rosa, Fernanda Andreia and Seixas, Flavio Augusto Vicente},
  title = {SARS-CoV-2 main protease inhibition by natural compounds},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2026},
  volume = {137},
  pages = {130664},
  doi = {10.1016/j.bmcl.2026.130664}
}
Kostenlos starten →